Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Telesis Bio, Inc. - Common Stock
(NQ:
TBIO
)
0.3300
-0.0242 (-6.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Telesis Bio, Inc. - Common Stock
< Previous
1
2
3
Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 28, 2023
Via
Benzinga
Telesis Bio to Present at Jefferies Healthcare Conference 2023
June 08, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
June 06, 2023
Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Telesis Bio Earnings Perspective: Return On Capital Employed
March 22, 2023
Via
Benzinga
A Preview Of Telesis Bio's Earnings
March 20, 2023
Via
Benzinga
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
June 05, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Secures Financing of $28.0 Million
May 31, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Present at SynBioBeta 2023
May 23, 2023
Highlighting application of the Molecular Biology Workstation to accelerating vaccine and biologics discovery
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
May 22, 2023
New Kit Enables Automation of DNA Cloning on the BioXp® System Beginning from Linear DNA, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit
May 18, 2023
New Kit Enables Automation of NGS Library Prep on the BioXp® System Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
May 15, 2023
Showcasing Automated Molecular Biology Workstation for Synthetic Biology and Genomics Applications
From
Telesis Bio
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 12, 2023
Via
Benzinga
Telesis Bio Reports First Quarter 2023 Financial Results
May 11, 2023
From
Telesis Bio
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 05, 2023
Via
Benzinga
Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023
April 27, 2023
From
Telesis Bio
Via
GlobeNewswire
Earnings Scheduled For May 11, 2023
May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...
Via
Benzinga
Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
March 31, 2023
New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Synthetic Biology Workstation
From
Telesis Bio
Via
GlobeNewswire
Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 22, 2023
Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 22, 2023
Via
Benzinga
Why GameStop Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
March 22, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 22, 2023
The biggest pre-market stock movers are making waves on Wednesday with huge gainers and losers worth watching this morning!
Via
InvestorPlace
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
March 21, 2023
From
Telesis Bio
Via
GlobeNewswire
Earnings Scheduled For March 21, 2023
March 21, 2023
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million.
Via
Benzinga
Telesis Bio to Present at Festival of Biologics Conference
March 16, 2023
Daniel Gibson, Ph.D., CTO and Co-founder to Present “Building Biology Overnight: Eliminating Synthesis Bottlenecks with Hands-free Automated Synthetic Biology Solutions”
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023
March 09, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Present at the Cowen 43rd Annual Healthcare Conference
February 27, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Releases BioXp® Select mRNA Synthesis Kit to Expand the Utility, Speed, and Impact of Its Automated Synthetic Biology Workstation
February 16, 2023
Scientists Can Now Begin the mRNA Synthesis Process from Their Own Sequence or Plasmid DNA
From
Telesis Bio
Via
GlobeNewswire
Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 11, 2023
Gainers Broadwind Inc (NASDAQ: BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.